12-06-2026 06:48 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Sun Pharmaceutical Industries Ltd.
Change Company   
BSE Code 524715
ISIN Demat INE044A01036
Book Value 93.24
NSE Code SUNPHARMA
Dividend Yield % 0.89
Market Cap 4305126.74
P/E 164.10
EPS 10.93
Face Value 1  
22-May-2026 Sun Pharma reports 26% rise in Q4 consolidated ne...
27-Apr-2026 Sun Pharmaceutical to acquire all outstanding sha...
27-Apr-2026 Sun Pharmaceutical Industries informs about inves...
27-Apr-2026 Sun Pharmaceutical Industries informs about press...
27-Apr-2026 Sun Pharmaceutical zooms on inking pact to acquir...
18-Apr-2026 Sun Pharmaceutical Industries informs about compl...
10-Apr-2026 Clarification sought from Sun Pharmaceutical Ind...
21-Mar-2026 Sun Pharmaceutical launches semaglutide injection...
21-Mar-2026 Sun Pharmaceutical Industries informs about press...
17-Mar-2026 Sun Pharmaceutical secures USFDA’s nod for review...
17-Mar-2026 Sun Pharmaceutical rises on securing USFDA’s nod ...
16-Mar-2026 Sun Pharmaceutical Industries informs about press...
01-Feb-2026 Sun Pharma reports 16% rise in Q3 consolidated ne...
01-Feb-2026 Sun Pharma gains on reporting 16% rise in Q3 cons...
01-Feb-2026 Sun Pharmaceutical Industries informs about newsp...
Page 1 of 3
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.